Chronic myeloid leukemia: reversing the chronic phase

Editorial

John M Goldman. J Clin Oncol. 2010.

. 2010 Jan 20;28(3):363-5.

doi: 10.1200/JCO.2009.26.5587. Epub 2009 Dec 14.

No abstract available

Comment on

Results of dasatinib therapy in patients with early chronic-phase chronic myeloid leukemia.
Cortes JE, Jones D, O'Brien S, Jabbour E, Ravandi F, Koller C, Borthakur G, Walker B, Zhao W, Shan J, Kantarjian H. Cortes JE, et al. J Clin Oncol. 2010 Jan 20;28(3):398-404. doi: 10.1200/JCO.2009.25.4920. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008620 Free PMC article. Clinical Trial.
Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase.
Cortes JE, Jones D, O'Brien S, Jabbour E, Konopleva M, Ferrajoli A, Kadia T, Borthakur G, Stigliano D, Shan J, Kantarjian H. Cortes JE, et al. J Clin Oncol. 2010 Jan 20;28(3):392-7. doi: 10.1200/JCO.2009.25.4896. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008621 Free PMC article.